• Non ci sono risultati.

Take home message

N/A
N/A
Info
Scarica
Protected

Academic year: 2022

Condividi "Take home message"

Copied!
21
0
0

Caricamento.... (Visualizza il testo completo ora)

Scarica adesso ( 21 pagine )

Testo completo

(1)

Farmaci, biomarcatori, efficacia e sostenibilità

Take home messages

Massimo Di Maio, MD

SCDU Oncologia Medica, AO Mauriziano, Torino Dipartimento di Oncologia, Università di Torino

massimo.dimaio@unito.it

(2)
(3)

…una sessione

ricca di prospettive ma soprattutto

di quesiti aperti!

(4)

Courtesy

of Romano Danesi

(5)
(6)

Kerr, ESMO meeting 2016

(7)

Kerr, ESMO meeting 2016

(8)

Courtesy

of Cristiano Rampinelli

(9)

Courtesy

of Cristiano Rampinelli

(10)

Immunoterapia: cosa chiedono i pazienti?

(11)

Immunoterapia: cosa chiedono i pazienti?

(12)

11. Treatment equity

In order to avoid individual economic concerns over the risk-benefit assessment of the treatment options, financial choices should be undertaken at the highest decisional level, as far as possible from the individual doctor-patient relationship.

Gori et al, Tumori Journal 2016 Dec 1;102(6):e25-e27.

(13)

Of course, this does not mean that doctors should not be

aware of the cost of the drugs: the economic implications of treatment decisions should be always taken into account.

Indeed, due to the relevance of these topics, decision-making should involve the contribution of all the stakeholders, the

doctors and even the patients themselves.

Di Maio M et al, ESMO Open 2016;1:e000109.

(14)

Richard Sullivan, ESMO meeting, October 10, 2016

Equitable and affordable cancer care: Is Europe a union for real?

(15)

“Il lavandino traboccante”

(16)

Il “fondo

speciale” per i farmaci

oncologici

Una soluzione provvisoria

(17)

Ridurre il numero di casi!

Nel breve termine:

“Precision medicine”

Nel medio termine:

Prevenzione!

Alla ricerca di soluzioni più durature…

(18)

Ridurre il costo dei farmaci!

Alla ricerca di soluzioni più durature…

(19)

ESMO

magnitude of benefit scale

ASCO value framework

Risultati delle

sperimentazioni cliniche

Approvazione da parte delle agenzie regolatorie

Decisione sul prezzo

Impiego

nella pratica clinica Inclusione dei farmaci

nelle linee-guida

(20)

ESMO

magnitude of benefit scale

ASCO value framework Definizione cruciale del

VALORE

Risultati delle

sperimentazioni cliniche

Approvazione da parte delle agenzie regolatorie

Decisione sul prezzo

Impiego

nella pratica clinica Inclusione dei farmaci

nelle linee-guida

(21)

Farmaci, biomarcatori, efficacia e sostenibilità

Take home messages

Massimo Di Maio, MD

SCDU Oncologia Medica, AO Mauriziano, Torino Dipartimento di Oncologia, Università di Torino

massimo.dimaio@unito.it

Riferimenti

Scarica adesso ( PDF - 21 pagine - 1.17 MB )

Documenti correlati

A graphical framework to evaluate risk assessment and information loss at individual level

We argue that in order to assess the disclosure risk of an individual record in a MFR two aspects have to be taken into account: (i) the number of records in the external archive

However, a strict way of conduct must be followed in order to avoid misinter- pretation of the data

To bring evidence for a transition between the film and bulk regimes we have analyzed the dependence of the free- electron mobility ␮ 共the mobility extracted from the I-V curves in

"Individual Heterogeneity and Pension Choices: How to Communicate an Effective Message? " – CeRP

< 5 Employees ≥ 1 um income income um wealth wealth risk aversion rence for shor ncial literacy eudo R-squar literacy (to * p<0.1; Av explaining w or a

US-China Trade War: Why the EU Should Take Sides and Favour the Rules-based Order

For this reason, the EU should keep equidistance vis-à-vis growing US- China rivalry, but at the same time, and depending on the issue, align temporarily with either one or the

24 Assessment and Treatment of Risk in the Clinic Setting

A Series of Clinic Visits Becomes a Program for Behavior Change Given constraints on time that a practitioner can spend in any one clinic visit and limita- tions on the ability of

These, therefore, should be transposed in the translated version of the audiovisual product in order to obtain the same effect on the audience the original writer(s) intended to

The expression “audiovisual translation” refers to all those translation techniques that aim to transfer the original dialogues of an audiovisual product into another

On service guarantees of fair-queueing schedulers in real systems

We have proved analytically the actual service properties of a large family of fair-queueing sched- ulers, ranging from WF 2 Q+ to its fast, approx- imated variants, and of

Conodonts across the Devonian/Carboniferous boundary in SE Sardinia (Italy)

Even if the upper part of the sections are very similar, ex- posing about 80 cm of Carbonifeous limestone, a difference in age is reported for the bed just above the